Primary aldosteronism

Journal of Endocrinological Investigation

Volumn 18, Issue 7, 1995, Pages 495-511

  Gordon, R D ^a  

^a GREENSLOPES PRIVATE HOSPITAL   (Australia)

Author keywords

Adenoma; adrenal; aldosterone; diagnosis; genetics; hyperplasia; multiple endocrine neoplasia; potassium; primary aldosteronism; renin; renin gene

Indexed keywords

ALDOSTERONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMILORIDE; AMLODIPINE; ANGIOTENSIN; ATENOLOL; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CORTICOTROPIN; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FELODIPINE; FLUDROCORTISONE; GLUCOCORTICOID; HYDRALAZINE; LABETALOL; METOPROLOL; NIFEDIPINE; POTASSIUM; PRAZOSIN; PROPRANOLOL; RENIN; SPIRONOLACTONE; STEROID; UNINDEXED DRUG; VASODILATOR AGENT;

ADRENAL CORTEX ADENOMA; ADRENAL GLAND; ADRENAL HYPERPLASIA; ADRENALECTOMY; ALDOSTERONE BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; ESSENTIAL HYPERTENSION; FAMILIAL DISEASE; GENE EXPRESSION; GENE FREQUENCY; GENETIC SCREENING; GLOMERULOSA CELL; GYNECOMASTIA; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HUMAN; HYPERTENSION; HYPOKALEMIC ALKALOSIS; PATHOPHYSIOLOGY; PATIENT SELECTION; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; REVIEW; SCREENING TEST; SODIUM RESTRICTION; STEROID BLOOD LEVEL; STROKE; TUMOR CLASSIFICATION; VENOUS BLOOD;

HUMAN; HYPERALDOSTERONISM; RENIN-ANGIOTENSIN SYSTEM; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0028818948     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/BF03349761     Document Type: Article

References (61)

1. The evolution of primary aldosteronism: 1954–1967
2. Suppression of plasma renin activity in primary aldosteronism: distinguishing primary from secondary aldosteronism in hypertensive disease
3. Normokalaemic primary aldosteronism, a detectable cause of curable “essential” hypertension
4. Commentary on incidence of primary aldosteronism
5. “Incidence of primary aldosteronism in uncomplicated “essential” hypertension. A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria”
6. Anomalous postural response of plasma aldosterone concentration in patients with aldosterone-producing adrenal adenoma
7. The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism
8. Control of plasma aldosterone in primary aldosteronism: distinction between adenoma and hyperplasia
9. Aldosterone-producing adenomas responsive to angiotensin pose problems in diagnosis
10. Angiotensin-responsive aldosterone-producing adenomas masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension
11. Histological as well as biochemical distinctiveness of atypical aldosterone-producing adenomas responsive to upright posture and angiotensin
12. Clinical and pathological diversity of primary aldosteronism, including a new familial variety
13. Primary aldosteronism: hypertension with a genetic basis
14. Primary aldosteronism — some genetic, morphological, and biochemical aspects of subtypes
15. Mineralocorticoid hypertension
16. Allelic losses on chromosome band 11q 13 in aldosterone producing adrenal tumors
17. Severe hypertension in primary aldosteronism and good response to surgery
18. Malignant hypertension due to an aldosterone-producing adrenal adenoma
19. Hypertension due to a renin-secreting tumour
20. Primary reninism
21. Genetics of primary aldosteronism
22. Surgical management of the ectopic ACTH syndrome
23. Ectopic ACTH syndrome. Diagnostic and therapeutic aspects
24. Occult ectopic secretion of corticotropine
25. Spectrum of mineralocorticoid hypertension
26. A licorice extract with desoxycortone-like action
27. Licorice-induced pseudoaldosteronism
28. Severe hypokalaemia with paralysis induced by small doses of licorice
29. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol
30. Syndrome of apparent mineralocorticoid excess: a defect in the cortisol — cortisone shuttle
31. Liddle’s syndrome: Heritable human hypertension caused by mutations in the β subunit of the epitheliai sodium channel
32. Renin in Liddle’s syndrome and in the syndrome of apparent mineralocorticoid excess
33. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity
34. Is aldosterone/renin ratio useful to screen a hypertensive population for primary aldosteronism?
35. Plasma aldosterone-plasma renin activity ratio. A simple test to identify patients with primary aldosteronism. Acta
36. Evidence that primary aldosteronism may not be uncommon — twelve percent incidence among antihypertensive drug trial volunteers
37. Gordon’s Syndrome: A sodium-volume-dependent form of hypertension with a genetic basis
38. Therapeutic effect of calcium blockade in primary aldosteronism (Abstract)
39. Effects of nisoldipine on sympathetic activity, the renin-angiotensin-aldosterone system, and watersodium-calcium metabolism in patients with essential hypertension
40. Effect of the calcium entry blocker isradipine (PN 200-110) in essential hypertension
41. Calcium channel blockade with nitrendipine: effects on sodium homeostasis, the renin-angiotensin system, and the sympathetic nervous system in humans
42. Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary aldosteronism
43. Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity
44. A chimaeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension
45. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase
46. A new genetic test for familial hyperaldosteronism tye I aids in the detection of curable hypertension
47. Possible association of aldosterone producing adenoma and non-fuctioning adrenal tumour
48. The diagnosis of primary aldosteronism
49. Hormonal evaluation of the patient with an incidentally discovered adrenal mass
50. Integrated imagery of adrenal disease
51. Endocrine evaluation of the incidentally discovered adrenal masses (Incidentalomas)
52. Incidentally discovered adrenal tumours: an institutional perspective
53. Does adrenocortical hyperplasia result in adrenocortical carcinoma? N
54. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone
55. Genetic aspects of adenomatosis of endocrine glands
56. Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type I
57. Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type I (MEN-I): Loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN-I locus